[PDF][PDF] Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms
Classical psychedelic drugs, eg, psilocybin and LSD, stimulate the serotonin 2A receptor (5-
HT2AR) and have recently been intensely investigated for their clinical effects in various …
HT2AR) and have recently been intensely investigated for their clinical effects in various …
[HTML][HTML] Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms
Classical psychedelic drugs, eg, psilocybin and LSD, stimulate the serotonin 2A receptor (5-
HT2AR) and have recently been intensely investigated for their clinical effects in various …
HT2AR) and have recently been intensely investigated for their clinical effects in various …
The renaissance in psychedelic research: what do preclinical models have to offer
KS Murnane - Progress in brain research, 2018 - Elsevier
Human research with psychedelics is making groundbreaking discoveries. Psychedelics
modify enduring elements of personality and seemingly reduce anxiety, depression, and …
modify enduring elements of personality and seemingly reduce anxiety, depression, and …
Psychedelics for mental health: a biochemical perspective
J González-Maeso - The Biochemist, 2024 - portlandpress.com
Psychedelics, such as psilocybin, mescaline and lysergic acid diethylamide (LSD), are
psychoactive substances that induce alterations in cognition, perception and sensory …
psychoactive substances that induce alterations in cognition, perception and sensory …
Psychedelics disrupt the functional hierarchy of the human brain
K Shinozuka - 2024 - ora.ox.ac.uk
Psychedelics, such as lysergic acid diethylamide (LSD), N, N-dimethyltryptamine (DMT), and
psilocybin, are hallucinogenic drugs that act on the 5-HT 2A receptor. Their effects can be …
psilocybin, are hallucinogenic drugs that act on the 5-HT 2A receptor. Their effects can be …
Serotonergic psychedelics: experimental approaches for assessing mechanisms of action
CE Canal - New Psychoactive Substances: Pharmacology, Clinical …, 2018 - Springer
Recent, well-controlled–albeit small-scale–clinical trials show that serotonergic
psychedelics, including psilocybin and lysergic acid diethylamide, possess great promise for …
psychedelics, including psilocybin and lysergic acid diethylamide, possess great promise for …
Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics
AM Jaster, J González-Maeso - Molecular psychiatry, 2023 - nature.com
Psychedelics, also known as classical hallucinogens, have been investigated for decades
due to their potential therapeutic effects in the treatment of neuropsychiatric and substance …
due to their potential therapeutic effects in the treatment of neuropsychiatric and substance …
Psychedelic drugs in biomedicine
Psychedelic drugs, such as lysergic acid diethylamide (LSD), mescaline, and psilocybin,
exert profound effects on brain and behavior. After decades of difficulties in studying these …
exert profound effects on brain and behavior. After decades of difficulties in studying these …
Bedside to bench: the outlook for psychedelic research
VP Acero, ES Cribas, KD Browne, O Rivellini… - Frontiers in …, 2023 - frontiersin.org
There has recently been a resurgence of interest in psychedelic compounds based on
studies demonstrating their potential therapeutic applications in treating post-traumatic …
studies demonstrating their potential therapeutic applications in treating post-traumatic …
The psychotherapeutic framing of psychedelic drug administration
Research on psychedelics as treatment for psychiatric disorders have gained renewed
momentum. The focus during this psychedelic resurgence has mainly been on refuting the …
momentum. The focus during this psychedelic resurgence has mainly been on refuting the …